AIDS Weekly articles from December 1992

AIDS Weekly archives from December 1992

Multi-site trial begins of the anti-AIDS drug, tat antagonist. (Ro 24-7429) (U.S. National Institute of Allergy and Infectious Diseases)
December 28, 1992... U.S. NIAID The first U.S. multi-center study examining the safety and effectiveness of a new drug, one that blocks replication of HIV by inhibiting a regulatory protein called tat, has begun at four sites of the AIDS Clinical Trials...

Company announces cap program for Zovirax brand acyclovir. (Burroughs Wellcome)
December 28, 1992... Burroughs Wellcome Burroughs Wellcome Co., Research Triangle Park, North Carolina, has announced a program that will place a cap on the annual cost of Zovirax brand acyclovir, its antiviral medication used in the treatment of a number...

AIDS study focuses on new approach to treatment: cell therapy. (Applied Immune Sciences Inc.)
December 28, 1992... Applied Immune Sciences Twenty AIDS patients will participate in a study to test the effectiveness of combatting AIDS-related Kaposi's sarcoma, which strikes cells lining blood vessels. The study will be the third, most extensive...

Study: teenage girls have more sex partners, at greater risk of STDs. (sexually transmitted diseases) (New York)
December 28, 1992... New York The percentage of sexually active teenage girls who have just one sexual partner has dropped by more than a third since 1971, while the number of those having four or more partners has doubled, according to a study. The...

Over $500,000 savings possible by screening high-risk women of childbearing age for HIV. (California)
December 28, 1992... California A recent management science study group, headed by Margaret L. Brandeau, Ph.D, of Stanford University, and Douglas K. Owens, M.D., Veterans' Affairs Medical Center, Palo Alto, California, has found that the primary benefits...

Legal needle exchange program reduces HIV exposure by 33 percent. (Yale University)
December 28, 1992... Yale University Approximately one-third of all AIDS cases nationwide can be traced directly or indirectly to intravenous drug use. But that percentage is much greater in certain geographic areas, including New Haven, Connecticut,...

Advisory council calls for needle, condom distribution. (New Jersey Governor's Advisory Council on AIDS)
December 28, 1992... New Jersey An advisory council told New Jersey Governor Jim Florio that the state should require schools to provide condoms to high school students by the fall of 1993 to fight the spread of AIDS. The council also urged the repeal...

New accelerated approval rules to be published. (U.S. Food and Drug Administration)
December 28, 1992... U.S. FDA The U.S. Food and Drug Administration (FDA) announced that it will soon publish new rules to speed the approval of drugs for patients with serious or life-threatening illnesses, such as AIDS, cancer and Alzheimer's disease....

Minorities said to account for 50 percent of AIDS cases in U.S. (U.S. National Commission on AIDS)
December 28, 1992... U.S. National Commission on AIDS Fifty percent of all new AIDS cases in the U.S. occur in minority communities beset by poverty and lack of adequate medical care, according to a member of the U.S. National AIDS Commission. Dr....

Town gives AIDS researchers glimpse of things to come. (Belle Glade, Florida) (U.S. Centers for Disease Control and Prevention)
December 28, 1992... U.S. CDC Once again, the small town of Belle Glade, Florida, has attracted national medical attention following a study which concludes heterosexual sex is the main cause of its AIDS cases. The research, which appears in the New...

AIDS education continues as an uphill battle in New York. (U.S. Centers for Disease Control and Prevention)
December 28, 1992... U.S. CDC Health advocates say AIDS education comes hard in minority communities, where concern with the disease often takes a back seat to other social problems, including drug abuse, inadequate healthcare and unemployment. "In...

Curable bacterial infection may be missed in AIDS patients. (Rochalimaea bacteria) (University of California, San Francisco)
December 28, 1992... University of California, San Francisco Physicians treating patients with HIV should be on the lookout for a life-threatening but curable bacterial infection that may be mistaken for other conditions such as Kaposi's sarcoma, according...

Study of cervical disease in HIV-positive women part of $1.14 million grants awarded to CBCT centers. (Community-Based Clinical Trial) (American Foundation for AIDS Research)
December 28, 1992... AmFAR The American Foundation for AIDS Research (AmFAR) announced the awarding of nearly $1,140,000 in Operating and Project Grants to Community-Based Clinical Trial (CBCT) centers in the U.S. and Puerto Rico. The latest cycle of...

GS 504 demonstrates antiviral activity against CMV. (cytomegalovirus) (Gilead Sciences Inc.)
December 28, 1992... Gilead Sciences Preliminary findings reported by W. Lawrence Drew, M.D., indicate that GS 504, Gilead Sciences' proprietary compound currently in Phase I/II clinical trials, has demonstrated antiviral activity against cytomegalovirus...

HIV vaccines move into Phase II testing in uninfected volunteers. (U.S. National Institute of Allergy and Infectious Diseases)
December 28, 1992... U.S. NIAID The first expanded, Phase II clinical trial of experimental vaccines to prevent HIV disease has begun in Seattle, Washington; Baltimore, Maryland; St. Louis, Missouri; Nashville, Tennessee; and Rochester, New York, through...

World AIDS Foundation. (funding objectives) (Research Report)
December 28, 1992... AUTHORS: P.T. 34, 42; K.W. 0715008, 0502017. Fogarty International Center. "The World AIDS Foundation (WAF) announces its intent to support research and education relating to Acquired Immunodeficiency Syndrome (AIDS) in the...

Expression of tuberculosis in the lung. (National Heart, Lung and Blood Institute research grant announcement) (Research Report)
December 28, 1992... World AIDS Foundation AUTHORS: RFA Available: HL-93-12L. National Heart, Lung and Blood Institute. "Letter of Intent Receipt Date: February 15, 1993. Application Receipt Date: April 13, 1993. Purpose: The National Heart,...

A high level of viral burden is associated with a rapid rate of disease progression in asymptomatic patients seropositive for human immunodeficiency virus type 1. (Research Report)
December 28, 1992... AUTHORS: W. Lu, J.W.K. Shih and J.M. Andrieu. Laboratory of Tumor-Immunology, Hopital Laennec, Universite de Paris V, Paris, France. Department of Transfusion Medicine, Warren G. Magnuson Clinical Center, National Institutes of Health,...

Comparison of trans-dominant inhibitory mutant HIV-1 genes expressed by retroviral vectors in human T lymphocytes. (Research Report )
December 28, 1992... AUTHORS: I. Bahner, C. Zhou, X.J. Yu, Q.L. Hao and D.B. Kohn. Children's Hospital Los Angeles, Los Angeles California. According to the authors' abstract submitted to the Thirty-Fourth Annual Meeting of the American Society of...

Low dose interferon-alpha for patients with severe HIV-related immune thrombocytopenia refractory to AZT. (Research Report)
December 28, 1992... AUTHORS: M.U. Rarick, B.M. Espina, T. Montgomery, J. Esplin, N. Deguzman and A.M. Levine. University of Southern California School of Medicine, Los Angeles, California; Northwest Kaiser Permanente, Portland, Oregon. According to the...

Zidovudine (AZT)-induced blockade of c-fos expression in bone-marrow progenitor cells (BMPC): reversal with interleukin-3 (IL-3) and erythropoietin (EPO). (Research Report)
December 28, 1992... AUTHORS: S.R. Gogu, B.S. Beckman, R.B. Wilson and K.C. Agrawal. Departments of Pharmacology and Pathology, Tulane University School of Medicine, New Orleans, Louisiana. According to the authors' abstract submitted to the Thirty-Fourth...

HIV infection of the BS-1 human stroma cell line: effect on murine hemopoiesis. (Research Report)
December 28, 1992... AUTHORS: H.N. Steinberg, C.S. Crumpacker and P.A. Chatis. Division of Hematology/Oncology, Beth Israel Hospital, Boston, Massachusetts. According to the authors' abstract submitted to the Thirty-Fourth Annual Meeting of the American...

Longitudinal study of homosexual couples discordant for HIV-1 antibodies in the Baltimore MACS study. (Multicenter AIDS Cohort Study) (Periodical Report)
December 28, 1992... SOURCE: Journal of Acquired Immune Deficiency Syndromes, December 1992;5(12):1204-1211. Despite frequent high-risk sexual activity with HIV-infected partners, none of 36 seronegative homosexual men enrolled in a longitudinal study...

Maintenance of CD4+ cells by thymopentin in asymptomatic HIV-infected subjects: results of a double-blind, placebo-controlled study. (Periodical Report)
December 28, 1992... SOURCE: AIDS, November 1992;6(11):1335-1339. Asymptomatic individuals treated with thymopentin for 24 or 52 weeks had higher CD4+ lymphocyte percentages than those receiving placebo in a 91-subject Phase II clinical trial. The...

Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. (Periodical Report)
December 28, 1992... SOURCE: American Journal of Medicine, November 1992;93(5):481-488. Both ceftriaxone and benzathine penicillin have high failure rates in HIV-infected patients treated for syphilis, a study indicates. The study also suggests that...

Tuberculous meningitis in patients with and without human immunodeficiency virus infection. (Periodical Report)
December 28, 1992... SOURCE: American Journal of Medicine, November 1992;93(5):520-524. HIV infection does not appear to influence the in-hospital mortality of tuberculous meningitis, a study indicates. However, HIV-infected patients with...

Different distributions of lung and blood lymphocyte subsets in pediatric AIDS or tuberculosis. (Periodical Report)
December 28, 1992... SOURCE: Annals of Clinical and Laboratory Science, November/December 1992;22(6):377-384. Absolute numbers and percentages of CD4+ and CD8+ T-lymphocytes and CD4/CD8 ratios are vastly lower in the bronchoalveolar fluid (BALF) than in...

Immunohistochemical and electron microscopic profiles of cutaneous Kaposi's sarcoma and bacillary angiomatosis. (Periodical Report)
December 28, 1992... SOURCE: Ultrastructural Pathology, November/December 1992;16(6):629-640. The spindle-shaped cells characteristic of Kaposi's sarcoma (KS) are endothelial in origin, immunohistochemical studies and electron microscopy indicate. ...

New recommendations call for four-drug regimen for initial treatment of TB. (U.S. Centers for Disease Control and Prevention/American Lung Association)
December 21, 1992... U.S. CDC / American Lung Association New tuberculosis (TB) containment recommendations issued in mid-December 1992 are among the first to call for a four-drug treatment regimen for the initial treatment of TB patients. The...

Prisons must test for TB. (American Society of Law and Medicine/United Hospital Fund)
December 21, 1992... Mandatory testing for tuberculosis (TB) is necessary for both prisoners and prison workers, but preventive treatment should not be mandatory for those who test positive for the TB bacterium, according to an official with the New York State...

Cost of AIDS in U.S. could rise to $15.2 billion by 1995. (U.S. Senate)
December 21, 1992... The cost of treating Americans infected with HIV could rise some 48 percent, to $15.2 billion a year, by 1995, health experts told a U.S. Senate panel. "The widespread use of expensive drugs has contributed to the high costs of...

Activists protest exclusion of women from testing. (experimental AIDS drug trials) (U.S. Food and Drug Administration)
December 21, 1992... A coalition of AIDS activists petitioned the U.S. government to change the rules that guide the testing of experimental drugs because they discriminate against women. The U.S. Food and Drug Administration (FDA) guidelines recommend...

HIV found in pre-ejaculatory fluid. (United Kingdom)
December 21, 1992... HIV, in addition to infecting semen, can lurk in the lubricant released before ejaculation, according to two studies of 23 infected men. "Many men believe oral sex without ejaculation is completely safe. That is clearly not the case...

p24-VLP AIDS treatment starts clinical trial in HIV+ patients. (British Bio-technology Group PLC)
December 21, 1992... British Bio-technology, Oxford, United Kingdom, announced a development in the progress of its AIDS treatment, p24-VLP. Following a successful Phase I trial, a pilot Phase II trial started December 10, 1992, in HIV-positive patients....

Anti-viral compound progresses to early Phase II clinical trials in hepatitis B. (lamivudine, or 3TC) (BioChem Pharma Inc.)
December 21, 1992... BioChem Pharma Inc., Laval, Quebec, announced that the anti-viral compound lamivudine (also known as 3TC in the treatment of HIV/AIDS) will soon enter early Phase II clinical trials in patients infected with the hepatitis B virus. In the...

Advisory panel recommends approval of female condom. (U.S. Food and Drug Administration Obstetrics and Gynecology Devices Panel)
December 21, 1992... The Obstetrics and Gynecology Devices Panel of the U.S. Food and Drug Administration (FDA) on December 10, 1992, unanimously recommended that the Reality female condom developed by Wisconsin Pharmacal Co. be approved by the FDA. If...

HIV protein binds to brain cells, triggers signal. (gp120) (Germany)
December 21, 1992... German researchers report the discovery of a receptor on CD4-negative brain cells that binds the HIV gp120 envelope glycoprotein and activates a signal of possible pathological significance. The signal leads to tyrosine phosphorylation...

Scientists create animal model of how HIV affects brain. (Johns Hopkins University)
December 21, 1992... A genetically altered mouse gives science the first laboratory animal that can be used to study how HIV infects cells in the brain, researchers report. In a study published in the journal Science December 11, 1992, scientists report...

Study addresses occupational risk of HIV infection among healthcare workers. (Stanford University/Dartmouth Medical School)
December 21, 1992... Concern about the occupational risk of HIV infection has led to anxiety among healthcare workers, contentious debates about HIV testing and diminished access to care for some HIV-infected persons. So says Douglas K. Owens, M.D., of...

Resistance to antivirals targeted to human immunodeficiency virus. (National Institute of Allergy and Infectious Diseases Program Announcement) (Research Report)
December 21, 1992... AUTHORS: PA Number: PA-93-31. National Institute of Allergy and Infectious Diseases. "Application Receipt Dates: January 2, May 1, September 1, 1993. Purpose: This Program Announcement (PA) is designed to stimulate research to:...

Knowledge, attitudes and practices related to HIV/AIDS and substance abuse patient education: a survey of health care providers in a public hospital. (Research Report)
December 21, 1992... AUTHORS: S. Perlman, M. Isham, B. Strausberg, W. Holzemer, S.B. Henry and C.A. Reilly. According to an abstract submitted by the authors to the 120th Annual Meeting of the American Public Health Association, held in Washington, D.C.,...

Kaposi's sarcoma as sexually transmissible infection. (Research Report)
December 21, 1992... AUTHORS: J. Elford, A. McDonald and J. Kaldor. National HIV Surveillance Committee, National Centre in HIV Epidemiology and Clinical Research, New South Wales, Australia. According to an abstract presented at the 5th National...

Thallium scanning in the diagnosis of Kaposi's sarcoma. (Research Report)
December 21, 1992... AUTHORS: Y. Singh, I. Gosbell, W. Fong, D. Goldstein, W. Handl and P. Jones. Prince Henry Hospital, Anzac Parade, Little Bay, Australia. According to an abstract presented at the 5th National Conference on AIDS, held in Sydney,...

Retinoic acids inhibit AIDS-Kaposi's sarcoma tumor cell growth in vitro and in vivo. (Research Report)
December 21, 1992... AUTHORS: J. Cai, R. Masood, G. Lin, B.M. Espina, R. Law, B. Aggarwahl and P.S. Gill. University of Southern California School of Medicine, Los Angeles, California; M.D. Anderson Hospital, Houston, Texas. According to an abstract...

AIDS-KS derived cultured spindle cells induce vascular hyper permeability which may be the cause of edema in patients with Kaposi's sarcoma. (Research Report)
December 21, 1992... AUTHORS: S. Nakamura, S. Sakurada, H.A. Weich, S. Rasheed and S.Z. Salahuddin. Institute of Molecular Medicine & Technology, Huntington Memorial Hospital, Pasadena, California; and Department of Medicine, University of Southern California...

California Consortium Treatment Group trial of ABV followed by maintenance therapy with interferon-alpha and ZDV in HIV-associated Kaposi's sarcoma. (adriamycin, bleomycin, vincristine; zidovudine) (Research Report)
December 21, 1992... AUTHORS: E. Feigal, A. Levine, E. Muchmore, L. Slater, B. Espina, A. McCutchan and P. Gill. University of California, San Diego, California (UCSD); University of Southern California, Los Angeles, California (USC); University of California,...

Low dose m-BACOD with concomitant dideoxycytidine (ddC) in AIDS-related lymphoma. (bleomycin, adriamycin, cytoxan, decadron) (Research Report)
December 21, 1992... AUTHORS: A.M. Levine, E. Katz-Willson, B. Espina, J. Esplin, A. Ortega, S. Rasheed, B. Nathwani and P.S. Gill. University of Southern California School of Medicine, Los Angeles, California. According to an abstract presented to the...

Perturbations of in vitro hematopoiesis in human marrow long term cultures with HIV-infected stromal layers. (Research Report)
December 21, 1992... AUTHORS: G.N. Schwartz, S.W. Kessler, L.M. Burrell, M.L. Francis, M.S. Meltzer and D.G. Wriqht. Walter Reed Army Institute of Research, Washington, D.C., and Naval Medical Research Institute, Bethesda, Maryland. According to the...

Anti-HIV-1 hammerhead ribozymes transduced by retroviral vectors inhibit HIV-1 replication in human T lymphocytes. (Research Report)
December 21, 1992... AUTHORS: C. Zhou, I. Bahner, G. Larson, J. Rossi and D.B. Kohn. Children's Hospital Los Angeles, California, and Beckman Research Institute of City of Hope, Duarte, California. According to the authors' abstract submitted to the Annual...

TNF-alpha stimulates growth of deltaTCS-1 cells but induces apoptosis in CD4 cells in cord-blood: a model for HIV-1 infection. (Research Report)
December 21, 1992... AUTHORS: R. Rossol, S.A.Klein, G. Geissler, G. Kojouharoff, E.B. Helm and D. Hoelzer. Department of Hematology, Oncology, University of Frankfurt, Frankfurt, Germany. According to the authors' abstract submitted to the Annual Meeting...

Large diurnal variation in CD4 cell count and T-cell function among drug users: implications for clinical practice and epidemiological studies. (Periodical Report)
December 21, 1992... SOURCE: AIDS, November 1992;6(11):1269-1272. CD4+ T lymphocyte counts in HIV-infected drug users vary widely during the day, a Dutch study shows. Lymphocyte reactivity, which has been suggested as a prognostic marker of HIV...

A simplified surveillance case definition of AIDS derived from empirical clinical data. (Periodical Report)
December 21, 1992... SOURCE: Journal of Acquired Immune Deficiency Syndromes, December 1992;5(12):1212-1223. An international working group has agreed upon a simplified clinical AIDS case definition for surveillance in areas where the U.S. Centers for...

Serological responses to mycoplasmas in HIV-infected and non-infected individuals. (Periodical Report)
December 21, 1992... SOURCE: AIDS, November 1992;6(11):1287-1292. The infrequent finding of antibodies to two species of mycoplasma implicated in AIDS pathogenesis - and the lack of correlation of such antibodies to HIV infection -argue against a role for...

Commentary: methods women can use that may prevent sexually transmitted disease, including HIV. (Periodical Report)
December 21, 1992... SOURCE: American Journal of Public Health, November 1992;82(11):1473-1478. While condoms remain the best method for preventing the sexual transmission of HIV, female-controlled methods such as diaphragm/spermicide use should be...

Community AIDS HIV risk reduction - the effects of endorsements by popular people in 3 cities. (Periodical Report)
December 21, 1992... SOURCE: American Journal of Public Health, November 1992;82(11):1483-1489. A program in which popular individuals in gay communities are recruited as peer counselors has demonstrably reduced risky sexual behavior in three cities, a...

Effectiveness in disease and injury prevention: AIDS community demonstration projects: implementation of volunteer networks for HIV-prevention programs - selected sites, 1991-1992. (Periodical Report)
December 21, 1992... SOURCE: Morbidity and Mortality Weekly Report, November 20, 1992. "States and cities have effectively used community-level intervention projects to reduce cigarette smoking and other risk behaviors associated with chronic disease;...

Current trends: HIV infection and AIDS - Georgia, 1991. (Periodical Report)
December 21, 1992... SOURCE: Morbidity and Mortality Weekly Report, November 20, 1992. "Public health surveillance efforts for AIDS in the United States have documented an increasing proportion of cases among persons who reside outside the largest...

Business Responds to AIDS program. (Periodical Report)
December 21, 1992... SOURCE: Morbidity and Mortality Weekly Report, November 20, 1992. "On December 1, 1992, CDC will initiate a new, long-term, primary prevention program for human immunodeficiency virus (HIV) education. This program, 'Business Responds...

Meeting addresses TB and HIV. ("The Dual Epidemics of Tuberculosis and AIDS") (American Society of Law and Medicine/United Hospital Fund)
December 14, 1992... How do the civil rights of the patient with tuberculosis balance against the rights of society to be protected against the disease? Health professionals from across the U.S. gathered in New York City on December 4-5, 1992, to discuss...

Cost of treating TB patients will rise. (American Society of Law and Medicine/United Hospital Fund)
December 14, 1992... The cost of treating tuberculosis (TB) patients in New York City in 1993 could be as high as $250 million, and the capital costs of completing a TB facility on Rikers Island will cost an additional $70 million, an expert on TB expenditures...

HIV-infected healthcare workers must be protected. (from tuberculosis) (American Society of Law and Medicine/United Hospital Fund)
December 14, 1992... Healthcare workers who are HIV-positive must be made aware of the extreme risks of being in routine contact with tuberculosis (TB) patients, and hospitals have to be made safer for these workers, two experts in TB and AIDS said recently at a...

Tuberculosis center opens. (Public Health Research Institute)
December 14, 1992... Public Health Research Institute (PHRI) President Lewis M. Weinstein announced the opening of the PHRI TB Center, a facility dedicated to the containment of the spread of tuberculosis (TB), particularly of multi-drug resistant (MDR-TB)...

Agency backs plans to ensure TB patients take medicine. (directly observed therapy) (U.S. Centers for Disease Control and Prevention)
December 14, 1992... Government and private researchers recommended that healthcare workers be sure tuberculosis (TB) patients take their medicine, even if it means watching them swallow it. The recommendation came jointly from the U.S. Centers for Disease...

Foundation funds tuberculosis research. (American Foundation for AIDS Research)
December 14, 1992... The board of directors of the American Foundation for AIDS Research (AmFAR) announced September 28, 1992, that six grants totalling $350,000 have been awarded as an emergency response to the nation's growing tuberculosis (TB) problem. ...

Lung Awareness Month focuses on tuberculosis. (American Lung Association)
December 14, 1992... During December 1992, Lung Awareness Month, the American Lung Association will be urging the public to learn about the prevention and control of tuberculosis (TB), which, after decades of decline, is now alarmingly on the rise. ...

Virulent mycoplasma may be AIDS cofactor. (Mycoplasma penetrans) (Armed Forces Institute of Pathology)
December 14, 1992... More than 40 percent of AIDS patients - but not patients with other immunological disorders - test positive for a newly discovered mycoplasma with pathological properties. Moreover, 20 percent of individuals with asymptomatic HIV...

Bispecific antibody found to significantly reduce infectivity of HIV. (American Society of Hematology)
December 14, 1992... A bispecific antibody has been demonstrated to facilitate the ability of immune cells, called monocytes, to inhibit infection by HIV, it was reported December 8, 1992, at the 34th Annual Meeting of the American Society of Hematology in...

Primitive hematopoietic cells are not susceptible to HIV-1 infection. (Research Report)
December 14, 1992... AUTHORS: K. Cornetta, K. Fife, E. Bruno, A. Moore, T. Hill and R. Hoffman. Indiana University School of Medicine, Indianapolis, Indiana. According to the authors' abstract submitted to the Thirty-fourth Annual Meeting of the American...

HIV disease does not further reduce quality of life in patients with hemophilia provided that they are employed. (Research Report)
December 14, 1992... AUTHORS: B. Djulbegovic, A. Huang, J. Birkimer, T. Hadley, D. Vaughn, G. Joseph and G. Goldsmith. University of Louisville, Departments of Medicine and Psychology, Louisville, Kentucky. According to the authors' abstract submitted to...

Thrombocytopenia in hemophiliacs infected with human immunodeficiency virus. (Research Report)
December 14, 1992... AUTHORS: W.C. Ehmann and M.E. Eyster. Pennsylvania State University College of Medicine, Hershey, Pennsylvania. According to the authors' abstract submitted to the Thirty-fourth Annual Meeting of the American Society of Hematology,...

Sustained zidovudine treatment on hematopoiesis in immunodeficient mice. (Research Report)
December 14, 1992... AUTHORS: V.S. Gallicchio, N.K. Hughes and K.F. Tse. Hematology/Oncology Division, Departments of Medicine and Clinical Sciences, University of Kentucky and Veterans Administration Medical Centers, Lexington, Kentucky. According to the...

Lymphoproliferative effusion in HIV-infected patients: model for pathogenesis and control. (Research Report)
December 14, 1992... AUTHORS: B.G. Herndier, J. Marsh, T. Nolan and M.S. McGrath. Departments of Laboratory Medicine and Pathology, University of California, San Francisco, at San Francisco General Hospital. According to the authors' abstract submitted to...

'It won't happen to me': perceived risk and concern about contracting AIDS. (Research Report)
December 14, 1992... AUTHORS: S.I. Mishra( 1), and S. Serxner( 2). (1)Public Policy Research Organization, University of California, Irvine, California; (2)Cancer Research Center of Hawaii, Honolulu, Hawaii. According to an abstract submitted by the...

Trends in HIV antibody testing in San Francisco, 1990-1991. (Research Report)
December 14, 1992... AUTHORS: L. Fischer-Ponce, S. Mills and V. Kegebein. San Francisco Department of Public Health, San Francisco, California. According to an abstract submitted by the authors to the 120th Annual Meeting of the American Public Health...

HIV prevention among Latinos: a comparison of Puerto Rican and Dominican prostitutes and crack users. (Research Report)
December 14, 1992... AUTHORS: S. Deren, J. Sanchez, M. Shedlin, R. Davis and M. Clatts. (Institution not furnished). According to an abstract submitted by the authors to the 120th Annual Meeting of the American Public Health Association, held November...

AIDS awareness of a low-income minority population in New Orleans. (Research Report)
December 14, 1992... AUTHORS: M. Shepard-Perry and K. Middleton. Tulane University, New Orleans, Louisiana. According to an abstract submitted by the authors to the 120th Annual Meeting of the American Public Health Association, held November 8-12, 1992,...

AIDS-related risk perceptions among low-income ethnic minority urban women in an AIDS epicenter: community-based survey. (Research Report)
December 14, 1992... AUTHORS: S.C. Kalichman, T.L. Hunter and J.A. Kelly. (Institution not furnished). According to an abstract submitted by the authors to the 120th Annual Meeting of the American Public Health Association, held November 8-12, 1992, in...

Supplying health services in a collaborative school-based framework: the experience of the Los Angeles County STD program. (sexually transmitted disease) (Research Report)
December 14, 1992... AUTHORS: H. Rotblatt, S.J. Rulnick, C.A. Todoroff, G.A. Richwald, C.L. White and J. Carrel. (Institution not furnished). According to an abstract submitted by the authors to the 120th Annual Meeting of the American Public Health...

State and demographic variation in HIV/AIDS knowledge, attitudes and beliefs (KAB). (Research Report)
December 14, 1992... AUTHORS: R.M. Brackbill and S. Blount. U.S. Centers for Disease Control and Prevention, Atlanta, Georgia. According to an abstract submitted by the authors to the 120th Annual Meeting of the American Public Health Association, held...

Comparison of STD patient risk assessment methods. (Research Report)
December 14, 1992... AUTHORS: B. Boekeloo, D.L. Rabin, L. Schiavo and J. Matthews. (Institution not furnished). According to an abstract submitted by the authors to the 120th Annual Meeting of the American Public Health Association, held November 8-12,...

Predictors of significant HIV-related weight loss. (Research Report)
December 14, 1992... AUTHORS: S. Rubb, N.M.H. Graham, D. Hoover, L.D. McCall and J.G. Palenicek. Department of Epidemiology, Johns Hopkins School of Hygiene and Public Health, Baltimore, Maryland. According to an abstract submitted by the authors to the...

AIDS knowledge in minorities: the significance of locus of control. (Research Report)
December 14, 1992... AUTHORS: J.H. Coverdale, J.F. Aruffo, V.N. Pavlik and C. Vallbona. (Institution not furnished). According to an abstract submitted by the authors to the 120th Annual Meeting of the American Public Health Association, held November...

Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. (Periodical Report)
December 14, 1992... SOURCE: Nature, November 26, 1992;360(6402):358-361. Processing of the HIV envelope proteins is mediated by human furin, and specific furin inhibitors interfere with the formation of infectious viral particles, German and Swiss...

Immunodeficiency and the risk of death in HIV infection. (Periodical Report)
December 14, 1992... SOURCE: The Journal of the American Medical Association, November 18, 1992;268(19):2662-2666. AIDS patients have only a 15 percent chance of HIV-related death before their CD4+ T lymphocyte counts drop below 50 cells/uL, a British...